Title of article
Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary Intervention Original Research Article
Author/Authors
Ehtisham Mahmud، نويسنده , , Jeffrey J. Cavendish، نويسنده , , Sotirios Tsimikas، نويسنده , , Lawrence Ang، نويسنده , , Cuong Nguyen، نويسنده , , Guilherme Bromberg-Marin، نويسنده , , Guido Schnyder، نويسنده , , Shahin Keramati، نويسنده , , Vachaspathi Palakodeti، نويسنده , , William F. Penny، نويسنده , , Anthony N. DeMaria، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
9
From page
2163
To page
2171
Abstract
Objectives
This study sought to determine the factors associated with suboptimal platelet inhibition (PI) with single- and double-bolus eptifibatide during percutaneous coronary intervention (PCI).
Background
Although PI ≥ 95% measured 10 min after glycoprotein IIb/IIIa inhibitor therapy is associated with improved outcomes following PCI, this level of PI often is not achieved.
Methods
We prospectively studied 150 patients undergoing PCI with single-bolus eptifibatide (180 μg/kg) (n = 100) and double-bolus eptifibatide (180 μg/kg administered 10 min apart) (n = 50) followed by standard infusion (2 μg/kg/min). Measuring platelet aggregation at baseline and at 10 min and 30 to 45 min after eptifibatide bolus, patients were classified as optimal responders (OPT) (≥95% PI) or suboptimal responders (sub-OPT) (<95% PI) based on 10-min PI after final bolus.
Results
Suboptimal PI was achieved in 61% of patients with single-bolus eptifibatide and in 36% with double-bolus eptifibatide. In the single-bolus group, sub-OPT had higher fibrinogen levels (324 ± 85 mg/dl vs. 259 ± 49 mg/dl, p = 0.0002), platelet counts (221 ± 70 vs. 186 ± 47, p = 0.008), and white blood cell counts (7.7 ± 2.3 vs. 6.6 ± 1.9, p = 0.02). In the double-bolus group, sub-OPT also had higher fibrinogen levels (324 ± 68 mg/dl vs. 278 ± 53 mg/dl, p = 0.01) and were more likely to be smokers (38.9% vs. 9.4%, p = 0.01). Multivariable analysis showed that fibrinogen level was the only independent predictor of suboptimal PI, with fibrinogen cutoffs at 375 and 325 mg/dl predicting suboptimal PI (single-bolus: 100% and 90.0%, respectively; double-bolus: 100% and 60%, respectively) with both doses.
Conclusions
During PCI, both single- and double-bolus eptifibatide provide suboptimal PI in a substantial proportion of patients. A fibrinogen level >375 mg/dl is a strong predictor of suboptimal PI.
Keywords
CK , PCI , C-reactive protein , Creatine kinase , PI , ROC , Glycoprotein , CRP , mace , Percutaneous coronary intervention , GP , major adverse cardiac events , receiver-operator characteristic , OPT , optimal responders , platelet inhibition , sub-OPT , suboptimal responders
Journal title
JACC (Journal of the American College of Cardiology)
Serial Year
2007
Journal title
JACC (Journal of the American College of Cardiology)
Record number
472578
Link To Document